Euroapi S.A. (LON:0EAP)

Market Cap	213.36M
Revenue (ttm)	760.15M
Net Income (ttm)	-108.00M
Shares Out	n/a
EPS (ttm)	-1.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Average Volume	2,828
Open	2.480
Previous Close	2.451
Day's Range	2.464 - 2.464
52-Week Range	1.889 - 5.792
Beta	0.65
RSI	45.53
Earnings Date	Jul 29, 2025

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. The company provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. It offers their products to pharmaceutical, generic drug manufactu...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2020
• Employees: 3,187
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0EAP

Financial Performance

In 2024, Euroapi's revenue was 919.20 million, a decrease of -9.79% compared to the previous year's 1.02 billion. Losses were -130.60 million, -31.15% less than in 2023.

Financial numbers in EUR